Transarterial Chemoembolization Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma (IDADOX): Protocol for a Randomized, Non-inferiority, Double-Blind Trial.

Jin Woo ChoiHyo-Cheol KimJiyeon HanMyoung-Jin JangJin Wook Chung

Published in: Cardiovascular and interventional radiology (2023)

ClinicalTrials.gov ( https://clinicaltrials.gov/ ). Identifier: NCT06114082. World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) ( https://trialsearch.who.int/Default.aspx ). Identifier: KCT0008166.

Keyphrases

clinical trial
phase iii
phase ii
double blind
radiofrequency ablation
study protocol
placebo controlled
open label
randomized controlled trial
functional connectivity
drug delivery
high throughput
liver metastases
resting state
cancer therapy
single cell